CSBR:NASDAQ
Champions Oncology Inc
$4.79
arrow_downward
-0.83%(-0.040) 1D
Nov 5, 10:37:06 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.76
High
$4.85
Low
$4.72
Mkt. cap
67.51M
Avg. vol.
9.24K
Volume
8.95K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.76
High
$4.85
Low
$4.72
Mkt. cap
67.51M
Avg. vol.
9.24K
Volume
8.95K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
FXStreet
·
40 minutes ago
Broad market selloff as Bitcoin touches $75k as S&P 500, Nasdaq, and global benchmarks face sharp downturn
qz.com
·
11 minutes ago
Dow futures: 4 macro triggers moving the Dow after the midterm elections
Devdiscourse
·
37 minutes ago
US STOCKS-Nasdaq set to confirm correction as AI stocks tumble
TradingView
·
1 hour ago
Midday Pulse: S&P 500 top intraday gainers
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth care
Industry-
Websitechampionsoncology.com